← Evidence map

ReviewInternational journal of clinical oncology2017

Targeting metabolic reprogramming in KRAS-driven cancers.

Kenji Kawada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

72 papers cite itlatest 60 shown

2017
…
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT0513224450 enrolled2024
Full record →Abstract, authors, funding and every citing paper · PMID 28647837